The weight-loss drug revolution

The weight-loss drug revolution

Up next

Why are more people suing businesses?

From humble beginnings in England in the 12th century, to landmark civil rights court cases in the US in the 1960s, class actions are now rarely out of the headlines.They’re a means of bringing together large groups of people – sometimes millions – under the umbrella of a collect ...  Show more

The book that built the modern economy

250 years ago, on the 9th of March 1776, a book was published that didn’t just explain the economy, it changed it. The Wealth of Nations, written by "the father of economics" Adam Smith, sparked debates that still rage today, shaping everything from global trade to how much you e ...  Show more

Recommended Episodes

The Big Business Behind Weight Loss Drugs
Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
Motley Fool Money

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey cau ...  Show more

The Ozempic Era of Weight Loss
The Daily

Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.

Dani Blum, a reporter for The Times, tells the st ...

  Show more

Terence Flynn: The Next Blockbuster for Pharma?
Thoughts on the Market

As new weight management medications are being developed, might the obesity market parallel the likes of hypertension or high blood pressure to become the next blockbuster Pharma category?


----- Transcript -----


Welcome to Thoughts on the Mark ...

  Show more